AMGN vs CVS
By Alex · Tickerpine
Amgen Inc. vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | CVS |
|---|---|---|
| Price | $358.33 | $104.34 |
| Market cap | $193.39B | $133.13B |
| P/E ratio | 24.9 | 45.6 |
| ROE | 101.32% | 3.75% |
| Profit margin | 20.96% | 0.72% |
| Revenue growth | 5.80% | 6.10% |
| Dividend yield | 2.81% | 2.55% |
| Beta | 0.42 | 0.62 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs CVS in plain English
- AMGN is the bigger company — about 1.5× the market cap of CVS.
- AMGN is cheaper on earnings (P/E 24.9 vs 45.6).
- AMGN earns a higher return on equity (101% vs 4%).
- CVS is growing revenue faster (6% vs 6%).
- AMGN has the higher dividend yield (2.81% vs 2.55%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.